ABSTRACT
INTRODUCTION
The Non-essential regions within this portion of the genome have been identified by the isolation of viable deletion mutants. NER-E1 is eleven base pairs within the repeated sequences which comprise the high affinity binding site for the large T-protein. Strain A2 virus has three AGAGGC sequences, while strain A3 virus has only two (15) . A large number of viable deletions have been obtained between the origin region and the beginning of the early coding sequences (16) (17) (18) (19) ; these define the limits of NER-E2.
We have been particularly interested in the region designated "A" in Figure 1 , between the replication origin and the beginning of late protein coding sequences. Region A includes the late region transcriptional promoter elements, the late mRNA leader sequence and the DNasel hypersensitive domain. Within it are also the sequences tandemly duplicated in certain Py variants which, unlike wild type virus, are able to grow in undifferentiated embryonal teratocarcinoma cell lines (20-23, see legend to Fig. 1 ). We report here the construction and characterisation of a number of mutants lacking sequence from region A. The viability of certain mutants defined the three nonessential regions, NER-L1, NER-L2 and NER-L3 (Fig. 1) . Results of experiments in which the phenotypes of nonviable mutants were determined using assays which separately measured viral DNA replication and early gene expression identified a sequence within region A absolutely required, in jns, for both functions. Insertion of Py region A into plasmids also containing rabbit p-globin genes dramatically enhanced the expression of these genes from their own promoters (J. de Villiers and W. Schaffner, submitted for publication). Its relationship to other eucaryotic "enhancer" sequences (24-28) is discussed.
METHODS

DNA replication assays:
Subconfluent cultures (50mm) of 2° mouse embryo fibroblasts or Py transformed mouse cells (COP c e l l s , see Results) were transfected with up to lOOng of recombinant plasmid DNA by the DEAE-Dextran method (31) . When the viral DNA inserts were excised from the vector before transfection, Py anti-serum was included in the culture medium to prevent reinfection. Viral DNA was extracted 72 hrs post-infection by the selective SDS method (32) . After ribonuclease treatment and deproteinization, the DNA was digested with restriction endonuclease Mbol (Biolabs). The digests were fractionated by agarose gel electrophoresis, transferred to nitrocellulose (33) and probed with nick-translated recombinant DNA containing the entire viral genome inserted into the BamHI site of plasmid pAT153 (34) . Gene expression assays: HeLa, F2408 r a t l (35) , or rat2 (the g i f t of W. Topp) cells (90mm cultures) were transfected with 20ug of recombinant DNA by the calcium phosphate method (36) as modified by Banerji et al (27) . At 60-72 hours post-transfection, cells on coverslips were stained for Py large T-protein by indirect immunofluorescence (37) using tumour-bearing rat serum kindly provided by S. Dilworth (ICRF), or cytoplasmic RNA was extracted (38) f o r subsequent h y b r i d i s a t i o n analysis. So measure early region protein synthesis, the cultures were labelled with S-methionine (0.5mCi per culture) for three hours. Proteins were extracted, immunoprecipitated, and separated on 15% SDS-polyacrylamide gels as described by Ito et al (37) . Construction of deletion mutants around PvuII sites by transfection of mouse cells with shortened linear viral DNA: DNA of dl28, a viable Py mutant (16) 
RESULTS
Deletions at 67 map units were not recovered when modified Py DNA was grown in mouse cells.
Our initial goal was to identify sequences involved in Py late gene expression by the isolation of deletions which were either viable or complemented by early gene ts mutants. To this end, viral DNA was modified around any of the four cleavage sites for restriction endonuclease fvull (see a. An arbitrary scale of -to ++++ is used to reflect visual comparison of gel band intensities. We do not consider difference between ++ and +++ to be beyond experimental error, b. The 33bp deletion extended from the PvuII cleavage site at 5267 into Ar.
pdl2006 additionally has an 85bp deletion extending into A E from the PvuII site at 5130. c. These deletion mutants do not contain an Xhol linker, d. Sequence analysis was not done. The deletion was approximately positioned by restriction enzyme analysis {AcxI, Xhol, £ v u l l , BamH-I). e. The deletion removes the £vull site at 67.4 mu but i t s extent into A. or A^ is not known, f . "none" indicate^ no effect of helper DNA on replication. "N.D"." indicates that tests were not done.
This mutant contains three Xhol linkers at the site of deletion.
66.8 mu (nt 5100). No other deletion mutant assayed formed plaques (Table 1) . Deletion mutants defective in early gene expression
We suspected that certain mutants were nonviable because of defects in early gene expression.
Other experiments done in our laboratory had shown that removal of sequence from 65.4-70.0 mu decreased the oncogenic transforming activity of the viral DNA in a progressive manner as the residual viral sequence between vector DNA and the PvuII site at 70.0 was shortened (P. Jat, A. Cowie, U. Novak, C. Tyndall, and R.K., submitted for publication). Immunofluorescence results are summarized in Table 2 . We used three different recipient cell lines, which were all non permissive for Py DNA replication: HeLa, F2408 (ratl) fibroblasts ( 
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(1) Large deletions extending across the \/&£ junction were similarly negative or severely depressed.
These data suggested that sequence elements located on either side of the PvuII site at 67.4 mu were important for early gene expression.
To correlate the immunofluorescence data with actual expression levels, we used the immunoprecipitation of S-labeled T-antigens to test c r i t i c a l mutants. This proved feasible only in HeLa cells. The results presented in Figure 4A show that large, middle and small T-proteins were readily detectable in HeLa cells transfected with the plasmid containing viral DNA with multiple Xhol linkers at 67.4 mu (p43.2b.67).
By contrast, deletion mutants which showed intermediate levels of T-positive HeLa cells (dl 2038 and dl 2039) had far less large T-protein (middle and small T antigens were undetectable). No large T-protein was found with the other mutants tested.
These data q u a l i t a t i v e l y confirm the conclusions derived from immunofluorescence experiments, but imply that the latter assay rather overestimated actual expression levels. Panel B: Sl-gel mapping (11,44) the 5' ends of deletion mutant early mRNAs. The 5'-P-labeled, single-stranded, Hinfl fragment of Py DNA from nucleotide 388 to 5077 (4) was annealed to lOyg of cytoplasmic RNA (38) from HeLa cells transfected with each of the following DNAs: 1. plasmid p43.2b.67; 2. a plasmid encoding only large-T protein (pPyLTl); 3. a plasmid encoding only middle-T protein (pPyMTl); 4. pdl2006; 5. pdl2023; 6. pdl2025; 7. pdl2038; 8. pdl2039; 9. pdl2121*; 10. pdl2035L.
Lane 6 was reference mRNA from virus infected 3T6 c e l l s .
The SI resistant products resolved on the 5% polyacrylamide urea gel (47) of ca 235 and 245 bases map the major early region cap sites at nt 145-155 (see Fig. 1 ).
We further assayed the quantity and quality of the early region mRNAs synthesized after transfection using nuclease Sl-gel mapping of the 5'-ends. Control plasmids (Figure 4B) Among deletion mutants, some replicated nearly as well as the wild-type, others replicated less well, very poorly, or not at all. This range of phenotype is indicated using an arbitrary scale (++++ to -) in the table. As might be expected, there was a general correlation between replication without helper and the ability of the mutant to express its early genes.
For example, viable mutant dl2038 replicated and expressed relatively well, whereas nonviable mutants dl2025 and dl2035 expressed very poorly and didn't replicate. There was, however, a curious exception. Nonviable mutant dl2039 (lacking 30bp from A L and 36 from A E ) expressed early protein and early region mRNA as well the viable mutant dl2038 (lacking 38bp from Ar), but it replicated far less well (compare Figure 4 with table 1) . Results of complementation assays, in which wild-type viral DNA retained in its vector was co-transfected with the mutants, were also surprising. In these assays, the mutant and helper DNAs could in general be distinguished by their Mbol restriction patterns, but in certain instances Mbol and Xhol digestion was necessary. Positive complementation was obtained with only one mutant (dl2121*, see below). Deletion mutants (such as dl2025 and dl2035) which did not replicate alone also did not replicate with helper. Mutants (such as dl 2020P and dl 2039) which replicated poorly by themselves were inhibited by addition of "helper" DNA (negative complementation). Control experiments using the large T temperature sensitive mutant, tsa (40), demonstrated that cotransfection could yield positive complementation (Table  1) .
In addition, the one exceptional deletion mutant, pdl2121*. was positively complemented. This mutant has three Xhol linker sequences inserted at the site of a deletion removing 82bp from region A. . Removal of two linker sequences (generating pdl 2121) restored much of the replicative ability of the mutant, but in this case added helper was slightly inhibitory such that, with helper, pdl 2121* and pdl 2121 replicated to similar extents.
We inferred from these data the tentative conclusion that manipulation of the DNA sequence within region A can cause a cis-acting impairment in viral DNA replication, in addition to the previously demonstrated defectiveness in early gene expression. The critical sequences are not continuous with the known replication origin region because at least 33bp can be removed from the origin proximal end of region A^ (viable deletion pdl 2012) without affecting viability or substantially decreasing replicative ability.
The negative complementation observed with several mutants suggested that they unsuccessfully competed with helper wild-type DNA for a limiting factor. It was therefore impossible to assess the actual replicative abilities of such mutants by cotransfection with helper DNA because the source of the large T-protein was also a competitive inhibitor. Fig 1 and Fig 3 ) . NER-L1 extends away from sequences known to be important for viral DNA replication by a minimum of 33 bp (nt 5267-5234; one deletion mutant of less than 5 bp previously described (17) lies within this region); the limit distal from the origin has not been determined. NER-L2 extends from nt 5130 toward the replication origin by at least 51 bp, whereas NER-L3 extends from the same position towards the late region by about 30 bp. We do not as yet know whether the short deletions spanning nt 5130 are viable, but we suspect they will be because such DNAs (dl 2004 and dl 2007) replicate well in mouse cells without helper (Table 1 ) . Larger deletions, such as dl 2039, which remove NER-L3 and much of NER-L2 (36 bp) were nonviable. For this reason we provisionally consider NER-L2 and NER-L3 as separate domains, either but not both of which can be removed without loss of viability.
Replication of mutant DNAs in
We were initially surprised to find that deletion mutants within region A (Fig 1) were defective in early gene expression. The A £ /A L junction is more than 300 bp 5 1 -to the principal early mRNA cap site (Kamen et al, submitted
for publication), and we know that these cap sites are transcriptional initiation points (A. Cowie, P. Jat, and R. Kamen, in preparation). The cap sites and the 'TATA' box which preceeds them are within NER-E2 (Fig. 1) . A viable deletion mutant (dl 75, Table 2 
